Application 209463
- Type
- NDA
- Sponsor
- HIKMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | POWDER;IV (INFUSION) | EQ 40MG BASE/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209463-001 | PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N209463-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2017-06-30 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / IV (INFUSION) | RLD, RS | 2017-06-30 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / IV (INFUSION) | RLD, RS | 2017-06-30 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / IV (INFUSION) | RLD, RS | 2017-06-30 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / IV (INFUSION) | RLD, RS | 2017-06-30 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / IV (INFUSION) | RLD, RS | 2017-06-30 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / IV (INFUSION) | RLD, RS | 2017-06-30 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / IV (INFUSION) | 2017-06-30 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / IV (INFUSION) | 2017-06-30 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N209463-001 | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-06-30 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N209463-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209463-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N209463-001 | AP | 1 | 6a471c1ec25d… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209463-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209463-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209463-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209463-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209463-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N209463-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209463-001 | AP | 1 | 79d66fd596c7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N209463-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Cardinal Health 107, LLC | 362229c5-7b28-4563-aa62-d97d06005480 | 2025-10-13 | Warnings, Adverse reactions | 209463 NDA209463 55154-7477 |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Civica, Inc. | c857dc41-7b47-4f26-a9f5-d76eb82b44ee | 2024-10-31 | Warnings, Adverse reactions | 209463 NDA209463 |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Hikma Pharmaceuticals USA Inc. | 1e102c44-232b-4aaf-b457-2a740c47193a | 2023-07-19 | Warnings, Adverse reactions | 209463 NDA209463 0143-9300 |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Hikma Pharmaceuticals USA Inc. | b02f3f85-8f9b-4d06-8eae-73e592626f3e | 2023-07-10 | Warnings, Adverse reactions | 209463 NDA209463 0143-9284 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0143-9284 | Pantoprazole Sodium | Pantoprazole Sodium | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0143-9284 | Pantoprazole Sodium | Pantoprazole Sodium | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0143-9284 | Pantoprazole Sodium | Pantoprazole Sodium | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0143-9284 | Pantoprazole Sodium | Pantoprazole Sodium | West-Ward Pharmaceuticals Corp | NDA | Current |
| 0143-9300 | Pantoprazole Sodium | Pantoprazole Sodium | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0143-9300 | Pantoprazole Sodium | Pantoprazole Sodium | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0143-9300 | Pantoprazole Sodium | Pantoprazole Sodium | West-Ward Pharmaceuticals Corp | NDA | Current |
| 55154-7477 | Pantoprazole Sodium | Pantoprazole Sodium | Cardinal Health | NDA | Current |
| 55154-7477 | Pantoprazole Sodium | Pantoprazole Sodium | Cardinal Health | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 74827 | SUPPL | 2023-07-20 |
| 74784 | SUPPL | 2023-07-19 |
| 70455 | SUPPL | 2022-03-10 |
| 70433 | SUPPL | 2022-03-07 |
| 69813 | SUPPL | 2022-01-05 |
| 65436 | SUPPL | 2020-12-01 |
| 65364 | SUPPL | 2020-11-30 |
| 63691 | SUPPL | 2020-06-24 |
| 63680 | SUPPL | 2020-06-24 |
| 55940 | SUPPL | 2018-10-15 |
| 55939 | SUPPL | 2018-10-15 |
| 55895 | SUPPL | 2018-10-11 |
| 52678 | ORIG | 2018-02-21 |
| 48906 | ORIG | 2017-07-05 |
| 48894 | ORIG | 2017-07-03 |